Thursday, 8 April 2010

CATCH THE BUZZ - Movento Cancelled...Kind Of

CATCH THE BUZZ

Movento Cancelled. Kind of.

From Mary Clock-Rust

 

By Bill Pritchard

EPA Cancels Spirotetramat Registrations,
   Could Issue New Approval for the Insecticide

 

The Environmental Protection Agency has issued a final order
   cancelling the registration of all products containing the
   insecticide spirotetramat following a federal court decision vacating
   the 2008 registration because EPA had failed to follow proper
   notice-and-comment procedures.

   Although the agency is canceling the registration in accordance with
   the December 2009 ruling by the federal court in New York, EPA also
   said it is proceeding on a possible new registration of spirotetramat
   because it appears to be less risky than alternative pesticides.
   EPA said in the April 5 order that it will allow sale, distribution,
   and use of existing stocks by persons other than spirotetramat's
   registrant, Bayer CropScience. “Use of existing stocks is permitted
   provided such use is consistent in all respects with the
   previously-approved labeling for the product,” it said.
   The agency also said it is proceeding on a possible new registration
   of spirotetramat.

 Bayer CropScience developed the insecticide to combat crop pests such
   as aphids, whiteflies, scales, mealybugs, and gall midges in crops
   including vegetables, cotton, and soybean, according to the company
   website. The chemical is the active ingredient in the Bayer
   CropScience products Movento, Spirotetramat Technical, and Ultor.

   Possible New Registration of Product
   EPA said it is treating as new the applications for spirotetramat
   registration that Bayer CropScience filed in 2008. EPA said it is
   also reviewing public comments submitted since the court vacated the
   registration and will “determine whether the spirotetramat
   applications for registration should be granted [and] what license
   conditions and label language would be appropriate.”

   The pesticide “appears to be less risky to the environment and to
   human health than many of the alternative insecticides used on the
   sites for which spirotetramat was approved,” it said.

   The U.S. District Court for the Southern District of New York in
   December upheld claims by the Natural Resources Defense Council and
   the Xerces Society that the agency failed to publish Federal Register
   notices or provide for public comment before approving the pesticide
   (NRDC v. EPA, S.D.N.Y., No. 09cv4317, 12/23/09; 247 DEN A-6, 12/30/09).

   In a fact sheet on spirotetramat, EPA said that it “did not publish a
   notice of registration in the Federal Register for any of these
   decisions until August 6, 2009, three months after the plaintiffs
   filed this lawsuit,” according to court documents.
   In a March 22 statement, the NRDC also called spirotetramat a
   “bee-toxic pesticide” that should not be sold until its effects are
   evaluated.

   “We remain hopeful” that the insecticide will ultimately be
   registered, Bayer CropScience spokesman Jack Boyne told BNA April 7.
   “It's a very effective product.”

  The company has asked the U.S. Court of Appeals for the Second
   Circuit to review the district court's order. The circuit court has
   yet to schedule a hearing, according to its docket, but last month it
   denied the company's motion to stay the district court's ruling
   pending appeal (NRDC v. EPA, 2d Cir., No. 10-253, motion denied
   3/10/10).

  Comments Favor Spirotetramat
   EPA said slightly less than 90 percent of the remarks submitted
   during a Feb. 26-March 29 comment period following the court ruling
   favored continued use and distribution of existing stocks of the
   insecticide. Those remarks “cited a number of situations in which
   spirotetramat has replaced older, more toxic chemistries, including
   organophosphates and carbamates,” the agency said.

   For example, the Pennsylvania Department of Agriculture said “there
   is no justification to burden businesses, and individuals currently
   in possession of products thought to be properly registered,”
   according to a March 4 EPA publication, “Spirotetramat—Comments
   received on the sale, distribution, and/or use of existing stocks.”

   The National Potato Council said that “providing for the continued
   use of existing stocks of spirotetramat is critical to not needlessly
   disrupting the on farm decision making process due to procedural
   issues in the legal system and with no demonstration of evidence
   against the safety of the use of spirotetramat.”

 Threat to Honey Bee Colonies?
   However, the National Honeybee Advisory Board said the pesticide
   “represents a threat to insect pollinators and specifically managed
   honey bee colonies.” The board asked EPA to “require the registrant
   (Bayer) to recall all existing product.”

   Aaron Colangelo, a senior attorney for the Natural Resources Defense
   Council, said in the organization's March 22 statement that “our
   national bee emergency continues, with estimates of winter colony
   losses topping 30 percent again this year. We simply cannot afford to
   run an unregulated experiment on the pollinators that are central to
   our food system.”


Protein feeding pays off with better bee health, better survival, better production, and better wintering.  Learn More.

 

 Find out What’s New At Mann Lake right Here

Subscribe to Malcolm Sanford’s Apis Newsletter right here For a comprehensive listing of beekeeping events around the country and around the globe, check out Bee Culture’s Global Beekeeping Calendar This message brought to you by Bee Culture, The Magazine Of American Beekeeping, published by the A.I. Root Company.

Got a NO BUZZ ZONE? Can’t keep bees where you live, or know someplace that beekeepers can’t be?

Send me an email, with NO BUZZ in the subject line and tell me where, with your first and last name…Bee Culture Magazine, thedailygreen.com and Haagan Daz Ice Cream want to know. Send to Kim@BeeCulture.com today!

 



 

No comments:

Post a Comment